Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1985-09-27
1988-04-26
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
G01N 3348
Patent
active
047403640
ABSTRACT:
A method of providing a diagnostic indicia which is predictive of the risk of a non-osteoporotic human being contracting osteoporosis as a consequence of being in a long-term hormonally agonadal state, which comprises the steps of determining the average ratio of calcium to creatinine in the urine or in the blood of that person, during a period when the person is ingesting only foodstuff sources of calcium and vitamin D, while in a hormonally gonadal state, and also while in a hormonally agonadal state; determining the magnitude of the difference in the ratio obtained in the latter state compared to the former state, a large difference being predictive of a high risk of that person contracting osteoporosis.
REFERENCES:
Abbasi et al., JAMA, vol. 255, No. 12, pp. 1600-1604, Predicting the Piedisposition to Osteoporosis (1986).
Hodgen et al I, Amer. J. N. Obsterics & Gynecology, vol. 127, No. 6, pp. 581-584 (1977).
Erb et al, J. Animal Science, vol. 30, No. 1 (1970).
Urago; Acta Pat. Hol. Jpn, vol. 32, No. 5, pp. 759-770 (1982).
Hodgen et al II, J. Animal Science, vol. 26, No. 3 (1967).
Miller et al, Calcif. Tissue Int. (38) pp. 62-65 (1986).
Dinner D. L.
Eastern Virginia Medical Authority
Hollrah Glennon H.
LandOfFree
Predicting predisposition to osteoporosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Predicting predisposition to osteoporosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Predicting predisposition to osteoporosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-818646